16 US companies filed quarterly results with the SEC (8-K Item 2.02). We read every one and called the likely one-week price move. Calls are graded in the open.
The company's net asset value is estimated to be between $12.25 and $12.75 per share as of September 30, 2026, which is a decrease from $13.44 per share as of June 30, 2026, and the company has taken on new debt with a 6.50% redeemable promissory note due 2029, which may indicate increased leverage and potential dilution risk, and realized losses on some investments, including a $5.6 million loss
OUR ANALYSIS → VIEW 8-K →The company announced a CEO transition with Warren Stone taking over as CEO and Tony Zook becoming Executive Chairman, with Stone's employment agreement including a base salary of $850,000 and a target annual incentive bonus of 100% of base salary, as well as annual equity incentive awards with an aggregate target value of approximately $8,000,000
OUR ANALYSIS → VIEW 8-K →The company reported preliminary annual revenue of $10.5 million and a record $4.5 million purchase order, but the information is subject to change and has not been audited, and the company faces various risks and uncertainties that may impact its future results.
OUR ANALYSIS → VIEW 8-K →The company's digital asset holdings, particularly its SKY tokens, have increased in value to approximately $180.2 million as of September 30, 2026, and it has earned approximately 34.6 million SKY in staking rewards, but this update is preliminary and unaudited, and the company has a history of private placements and complex financial transactions, including a recent $134 million private placemen
OUR ANALYSIS → VIEW 8-K →Athene Holding Ltd. reports preliminary estimates for alternative net investment income of $375 million (pre-tax) for the third quarter, a 10% annualized return on alternative net investments. However, the results are subject to change as the company has not completed its financial closing procedures and the actual results may differ materially.
OUR ANALYSIS → VIEW 8-K →Apollo Global Management reported preliminary estimates of $375 million in alternative net investment income for Q3, a 10% annualized return, but this is not a significant surprise as it's within the expected range and not a full earnings report.
OUR ANALYSIS → VIEW 8-K →The company's preliminary estimates for investment income from alternative investments are below management's long-term expected return, with a midpoint annualized return of approximately 5% compared to the expected 12%. This shortfall may negatively impact the stock price.
OUR ANALYSIS → VIEW 8-K →AbbVie's adjusted diluted EPS guidance for Q3 2026 is $3.73-$3.77, and full-year 2026 guidance is $13.76-$13.96, including the impact of acquired IPR&D and milestones expense, which is expected to be $216 million for Q3 2026, representing an unfavorable impact of $0.11 to both GAAP diluted EPS and adjusted non-GAAP diluted EPS.
OUR ANALYSIS → VIEW 8-K →The company has provided preliminary unaudited information on cost of revenue for the year ending December 31, 2026, but this information is subject to completion of financial closing procedures and has not been audited or reviewed by the company's independent registered public accounting firm, and thus may not be reliable or final.
OUR ANALYSIS → VIEW 8-K →Lucid Group, Inc. announced Q3 production and delivery totals, with 2,954 vehicles produced and 3,806 vehicles delivered, and demand for the Lucid Gravity regaining momentum, but this information is likely already priced in and lacks quantified financial surprises.
OUR ANALYSIS → VIEW 8-K →The monthly cash distribution of $0.355450 per unit is higher than the previous month's due to increased oil production and natural gas and oil pricing, which may positively impact the stock price. However, this information is likely already reflected in the stock's current price, given the routine nature of the announcement.
OUR ANALYSIS → VIEW 8-K →InTest Corporation expects record orders for Q3 2026 and revenue at the high end of guidance ranges for Q3 and full year 2026, driven by record back-end semiconductor orders and growth in demand for advanced semiconductor test solutions.
OUR ANALYSIS → VIEW 8-K →The company is redeeming its 8.50% Senior Notes due 2026 at par, which may reduce its debt burden, but the preliminary financial information is unaudited and subject to change, and the announcement lacks quantified surprises or significant new developments.
OUR ANALYSIS → VIEW 8-K →The company reports double-digit growth in SOL per share and over 100% growth in NAV per share, with an 11% increase in SOL holdings since August 12, but this news may already be priced in, and the $300 million CHAD ATM could be a source of dilution
OUR ANALYSIS → VIEW 8-K →Termination of the merger agreement with Fathom Holdings, Inc. and strong revenue momentum with gross margin expected to exceed 30% are notable, but the lack of a confirmed takeover or quantified earnings surprise limits the impact.
OUR ANALYSIS → VIEW 8-K →Alector has entered into a License Agreement with Genentech, granting exclusive worldwide rights to develop and commercialize its AL050 program in exchange for a $100 million upfront payment and up to $1.17 billion in potential milestone payments, as well as tiered royalties on net sales. This deal significantly bolsters Alector's cash position, enabling it to fund operations into 2029.
OUR ANALYSIS → VIEW 8-K →The material filings, RNS and EU notices in one email every market day, read and scored by AI.
Subscribe free →Oct 2 (7) · Oct 1 (13) · Sep 30 (14) · Sep 29 (8) · Sep 28 (8) · Sep 25 (5) · Sep 24 (11) · Sep 23 (7) · Sep 22 (6) · Sep 21 (4) · Sep 18 (8) · Sep 17 (3) · Sep 16 (3) · Sep 15 (7) · Sep 14 (11) · Sep 11 (13) · Sep 10 (18) · Sep 9 (27) · Sep 8 (17) · Sep 4 (4)